ASPEN AEROGELS INC
Close on Oct 19, 2026
- Market cap
- $440.99M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 5, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | Before market open | $49.80M | $-0.28 | $-0.22 |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | Before market open | $37.90M | $-0.29 | $-0.28 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 25, 2026 | Before market open | $41.30M | $-0.88 | $-0.34 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | Before market open | $73.00M | $-0.08 | $-0.06 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 7, 2025 | Before market open | $78.00M | $-0.11 | $-0.04 |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | Before market open | $78.70M | $-3.67 | $-0.06 |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 12, 2025 | After market close | $123.10M | $0.14 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Oct 16, 2024 | Before market open | $117.00M | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 7, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 1, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 12, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Aug 6, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Capital Expenditures, excluding costs related to the restoration of the East Providence facility | FY 2026 | $10.00M | Maintained |
| Adjusted EBITDAnon-GAAP | Q3 2026 | $7.00M to $15.00M | New |
| Net loss per shareGAAP | Q3 2026 | $-0.11 to $-0.07 | New |
| Net lossGAAP | Q3 2026 | -$9.00M to -$6.00M | New |
| European Thermal Barrier 2026 revenue outlook | 2026 | $20.00M to $30.00M | New |
| Revenue | Q3 2026 | $65.00M to $80.00M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Aspen Aerogels filed with the SEC
September 15, 2026 ASPEN AEROGELS NYSE: ASPN INVESTOR PRESENTATION r D e c k | S e p t e m b e r 1 5 , 2 0 2 6
Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels Begins Staged Restart of East Providence Facility
Executive or director change · Shareholder vote results · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports First Quarter 2026 Financial Results and Recent Business Highlights
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels Provides East Providence Facility Update
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels Announces Amendment to MidCap Credit Facility
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
First Quarter 2025 Financial Results and Recent Business Highlights
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal Year
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Third Quarter 2024 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
ASPEN AEROGELS, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF 4,250,000 SHARES OF COMMON STOCK
Material agreement · Other events · EX-99.1 to Form 8-K
Conditional Commitment for Proposed DOE Loan and Provides Q3 2024 Preliminary Financial Results
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Second Quarter 2024 Financial
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels Announces Thermal Barrier Award from Valmet Automotive for
Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports First Quarter 2024 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Business Highlights
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Provides Business Update
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Announces $75 Million Registered Direct Offering
Material agreement · Other events · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Announces Additional EV Thermal Barrier Commercial Award and Provides Update on U.S. Department of Energy Loan Application Status
Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Provides Commercial and Full Year 2023 Financial Outlook Updates
Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Appoints Stephanie Pittman Chief Human Resources Officer
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Second Quarter 2023 Financial Results and Recent Business Highlights
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports First Quarter 2023 Financial Results and Recent Business Developments
Results of operations · Regulation FD disclosure · EX-99 to Form 8-K
ASPEN AEROGELS SUES KOREAN AEROGEL Supplier and Norwegian Parent Company FOR PATENT INFRINGEMENT
Regulation FD disclosure · EX-99 to Form 8-K
Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal 2022 Financial Results and Recent Business Developments
Results of operations · Regulation FD disclosure · EX-99 to Form 8-K
Aspen Aerogels, Inc. Reports Third Quarter 2022
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Announces Release of Inaugural ESG Highlights Report
Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Second Quarter 2022 Financial Results and Recent Business Developments
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Announces its Decision Not to Proceed with Concurrent Public Offerings of
Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Provides Business Update
Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Appoints Virginia H. Johnson Chief Legal Officer,
Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports First Quarter 2022 Financial Results and Recent Business Developments
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels to Open Advanced Manufacturing Facility in Bulloch County
Material agreement · Other events · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal 2021 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels Announces $150 Million Investment from Koch Strategic Platforms
Material agreement · New financial obligation · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Aspen Announces CFO Retirement Plan and Strategic Leadership Appointments
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Aspen Aerogels, Inc. Reports Third Quarter 2021 Financial Results and Recent Business Developments
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K